NIH Guide: Weekly Index for July 16, 2021

Funding Opportunities

• Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
  (PAR-21-247)
  National Human Genome Research Institute
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
  (PAR-21-258)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 10, 2021; January 25, 2022; May 25, 2022; January 25, 2023; May 25, 2023
• NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
  (PAR-21-265)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 7, 2021.
• NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
  (PAR-21-266)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 5, 2021.
• NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
  (PAR-21-267)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 7, 2021.
• Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
  (PAR-21-274)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
  (PAR-21-276)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Applications for this limited competition FOA will be accepted on a rolling basis, beginning July 16, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed)
  (RFA-AG-22-015)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2021
• Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed)
  (RFA-AG-22-021)
  National Institute on Aging
  Application Receipt Date(s): November 02, 2021
• Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required)
  (RFA-AG-22-024)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2021
• Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
  (RFA-CA-21-038)
  National Cancer Institute
  Application Receipt Date(s): October 07, 2021
• Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-039)
  National Cancer Institute
  Application Receipt Date(s): October 07, 2021
• Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)
  (RFA-DK-21-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 03, 2022
• Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
  (RFA-DK-21-003)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 03, 2022
• Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed)
  (RFA-DK-21-013)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 20, 2021
• Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  (RFA-HL-22-014)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 08, 2021
• Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional)
  (RFA-LM-21-002)
  National Library of Medicine
  Application Receipt Date(s): September 17, 2021
• BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
  (RFA-MH-21-205)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
  (RFA-RM-21-025)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 24, 2021